From Our Partners
Wednesday, June 29, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosurveillance

First Case of Novel Coronavirus in France

by Global Biodefense Staff
May 8, 2013

Novel Coronavirus (Rocky Mountain Labs)French health authorities today announced a 65-year old citizen is hospitalized in intensive care with an acute respiratory infection after having contracted the emerging novel coronavirus (nCoV). 

Where or how the patient contracted nCoV is still being investigated, but the Health Ministry reports the Frenchman fell ill in April after returning from a trip to the United Arab Emirates.

Laboratory analysis by the Pasteur Institute confirmed the virus as nCoV. French government surveillance screening programs have identified 19 suspicious cases thus far, but this is the only case to date that has been positive for the emerging disease.

The nCoV has claimed seven lives since it was first identified in September 2012. Most cases have been in the Middle Eastern countries of Jordan, Qatar, Saudi Arabia and the United Arab Emirates; three cases in the United Kingdom were linked to an infected family member who had recently traveled from Saudi Arabia.

“While the cases are sporadic, we need to understand more about how people are falling ill with this disease…we are concerned about possible human-to-human transmission, even if limited,” said Glenn Thomas, a World Health Organization spokesman (Source: Wall Street Journal).

From Our Partners
Tags: CoronavirusEmerging ThreatsMERS-CoV

Related Posts

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps
Outbreak News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance
Biosurveillance

The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance

June 9, 2022
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC